Advanced search
Publication Cover
Current Medical Research and Opinion Volume 32, 2016 - Issue 5
Submit an article Journal homepage
739
Views
10
CrossRef citations to date
0
Altmetric
Oncology

Treatment patterns, overall survival, healthcare resource use and costs in elderly Medicare beneficiaries with chronic myeloid leukemia using second-generation tyrosine kinase inhibitors as second-line therapy

B. Douglas SmithSidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA;
,
Jun LiuHarvard University, Cambridge, MA, USA;
,
Dominick Latremouille-ViauAnalysis Group Inc., Montreal, Quebec, Canada; Correspondence[email protected]
,
Annie GuerinAnalysis Group Inc., Montreal, Quebec, Canada;
,
Daniel FernandezHarvard University, Cambridge, MA, USA;
&
Lei ChenNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA
Pages 817-827 | Received 14 Sep 2015, Accepted 06 Jan 2016, Published online: 10 Feb 2016

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Fiorenzo Santoleri, Elena Ranucci, Gaetano La Barba, Irene Colasanto, Matilde Scaldaferri, Francesco Cattel, Francesca Federici, Chiara Rossi, Katiuscia Di Biagio, Anna Rita Scortechini, Felice Musicco, Giancarlo Torquati, Angela Frazzetto, Antonietta Vozza, Caterina de Rosa, Rosaria Lanzillo, Maria Monteverde, Luigia Luciano, Fabrizio Pane, Arianna Pasquazi, Maria Grazia Celeste, Maria Cantonetti, Luca Franceschini, Manuela Rizzo & Alberto Costantini. (2021) Adherence, persistence and efficacy of dasatinib and nilotinib in the treatment of patients resistant or intolerant to imatinib with chronic myeloid leukemia in chronic phase: an Italian multicenter study over two years in real life. Current Medical Research and Opinion 37:3, pages 477-481.
Read now

Articles from other publishers (9)

Nicole Held & Ehab L. Atallah. (2023) Real-world Management of CML: Outcomes and Treatment Patterns. Current Hematologic Malignancy Reports.
Crossref
Ehab L. Atallah, Rodrigo Maegawa, Dominick Latremouille-Viau, Carmine Rossi, Annie Guérin, Eric Q. Wu & Pallavi Patwardhan. (2022) Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States. Journal of Health Economics and Outcomes Research 9:2.
Crossref
Ehab Atallah, Rodrigo Maegawa, Dominick Latremouille-Viau, Carmine Rossi, Annie Guérin, Eric Wu & Pallavi Patwardhan. (2022) Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States. Journal of Health Economics and Outcomes Research 9:2, pages 19-29.
Crossref
Ankur A. Dashputre, Katie S. Gatwood & Justin Gatwood. (2020) Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Journal of Managed Care & Specialty Pharmacy 26:2, pages 186-196.
Crossref
Raul Cordoba, Valentin Garcia-Gutierrez & Juan M. Alonso-Dominguez. 2020. Geriatric Oncology. Geriatric Oncology 535 547 .
Jonathan Webster & B. Douglas Smith. (2019) The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia. Clinical Therapeutics 41:2, pages 336-349.
Crossref
Karen Seiter, Dominick Latremouille-Viau, Annie Guerin, Briana Ndife, Karen Habucky, Derek H. Tang, Irina Pivneva, Patrick Gagnon-Sanschagrin & George J. Joseph. (2018) Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States. Advances in Therapy 35:10, pages 1671-1685.
Crossref
Raul Cordoba, Valentin Garcia-Gutierrez & Juan M. Alonso-Dominguez. 2018. Geriatric Oncology. Geriatric Oncology 1 13 .
Raul Cordoba, Valentin Garcia-Gutierrez & Juan-Manuel Alonso. 2018. Geriatric Oncology. Geriatric Oncology 1 13 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.